| Patent No. | Patent Title: |
| 6737059 | Methods of inhibiting inflammatory processes and alleviating symp... |
| 6221629 | Expression vectors and process for producing human B cell surface... |
| 6194557 | Nucleic acid molecules encoding Bap-1 proteins |
| 6143297 | Methods of promoting immunopotentiation and preparing antibodies ... |
| 6124430 | Human brain natriuretic peptides |
| 6123915 | Methods for using agents that bind to VCAM-1 |
| 6113901 | Methods of stimulating or enhancing the immune system with anti-C... |
| 6106832 | Treatment of individuals exhibiting defective CD40L |
| 6090924 | Human-Human CLNH5-specific antibodies |
| 6087329 | CD40 ligand polypeptide |
| 6083747 | Method of preparing hematopoietic stem cells with gp105-specific ... |
| 6074642 | Use of antibodies specific to human complement component C5 for t... |
| 6075128 | Materials and methods for isolating IgA immunoglobulins |
| 6071519 | Immunotoxins specific for CD86 expressing cells |
| 6068840 | Recombinant CDR-grafted and chimeric anti-IL-8 antibodies contain... |
| 6066321 | Method for antagonizing vascular adhesion protein-1 (VAP-1)-media... |
| 6063906 | Antibodies to integrin alpha subunit |
| 6060588 | Bap-1 proteins |
| 6060054 | Product for T lymphocyte immunosuppression |
| 6056957 | Humanized monoclonal antibodies against human interleukin-5 |
| 6056959 | CD40 antigen antibody complex |
| 6056956 | Non-depleting anti-CD4 monoclonal antibodies and tolerance induct... |
| 6051693 | CLNH11-specific antibodies |
| 6051228 | Antibodies against human CD40 |
| 6051229 | Human-human hybridom for neoplasms CLNH5 and CLNH11 specific anti... |
| 6051387 | Methods of determining the presence of a neoplasm with CLNH5- and... |
| 6048972 | Recombinant materials for producing humanized anti-IL-8 antibodie... |
| 6046162 | Suppression of cell proliferation by decorin |
| 6033667 | Method for detecting the presence of P-selectin |
| 6024956 | Method to treat inflammation with humanized anti-IL-8-antibodies |
| 6017527 | Activated dendritic cells and methods for their activation |
| 6015897 | Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota |
| 6013519 | Monoclonal antibodies to antigens expressed by hematopoietic ... |
| 6007816 | Methods of using CD44-specific antibodies |
| 6004552 | Methods of blocking B cell proliferation using anti-CD40 monoclon... |
| 6001358 | Humanized antibodies to human gp39, compositions containing there... |
| 6001356 | Method of inhibiting tissue destruction in autoimmune disease usi... |
| 5997867 | Method of using humanized antibody against CD18 |
| 5993816 | Methods to inhibit humoral immune responses, immunoglobulin produ... |
| 5994524 | Polynucleotides which encode reshaped IL-8-specific antibodies an... |
Quotables 
PatentStorm News
